Exposure to pesticides is associated with an increased risk for pancreatic adenocarcinoma, according to two French studies presented at the Francophone Days of Hepatology, Gastroenterology, and […]

The US Food and Drug Administration has approved danicopan (Voydeya, AstraZeneca) as an add-on therapy to treat extravascular hemolysis in adults receiving ravulizumab or eculizumab for […]

Several new clinical trials in prostate cancer have started recruiting in recent months. Maybe one of your patients could benefit from enrolling? Metastatic castration-sensitive prostate cancer. Adults […]

Treatment decisions about the care of patients with non–small cell lung cancer (NSCLC) that has metastasized to the brain should always be made by a multidisciplinary […]

Many women with cancer want advice for managing sexual function issues, and clinicians are tuning in, new studies suggest. Decreased sexual function is a side effect […]

TOPLINE: Treatment with palliative “Quad Shot” radiotherapy with concurrent immunotherapy appears safe and significantly improves local control in symptomatic patients with recurrent and metastatic head and […]

TOPLINE: Despite concerns about malpractice risk among physicians, investigators found no successful malpractice litigation related to active surveillance as a management strategy for low-risk cancers. METHODOLOGY: […]

TOPLINE:  “Optimizing vaccination status should be considered a key element in the care of patients with cancer,” according to the authors of newly released American of […]

Minimally invasive cytoreductive surgery for epithelial ovarian cancer appears to be safe and does not compromise survival, compared with open surgery, when patients have completely resected […]